Abstract:AIM: To obtain the antagonistic peptides that have effect to prevent metastasis of Hepatocellular Carcinoma (HCC). METHODS: Nine pieces of high affinity peptides (AP-1-AP-9) were obtained by pure HAb18G/CD147 antigen to panning phage displayed random peptide library. MTT assay was used to test toxicity of AP-1-AP-9 on human hepatocellular carcinoma cell (HHCC); Gelatin zymogram was used to analyze the effects of AP-1-AP-9 on activation and production of matrix metalloproteinase (MMPs); Matrigel-boyden chamber method was used to evaluate inhibitory abilities of AP-1-AP-9 on tumor cell invasion and metastasis; Inhibitory effect of AP-1-AP-9 on HHCC adhesion to extracellular matrix protein and fb cells were investigated. The influences of AP-1-AP-9 on HHCC chemotaxis migration were also tested. RESULTS: AP-1-AP-9 has no toxicity on HHCC; AP-1, AP-6 and AP-9 could inhibit production and activation of MMP-2; the amounts of infiltrative cells in AP-1, 3, 6, 7, 8, 9 experimental groups are significantly less than that in control group (P <0.05), and inhibition rate was 78.22%, 90.1%, 62.83%, 56.44%, 68.32%, 81.19 %, respectively; AP-1-AP-9 had no effects on HHCC adhesion to matrigel and fibronectin (FN), whereas AP-3 and AP-9 could inhibit HHCC adhesion to collagen IV and laminin (LN), AP-1, AP-6 and AP-9 could inhibit HHCC adhesion to fb. AP-6 could inhibit chemotaxis migration of HHCC with the inhibitory rate of 54% without statistical significance (P>0.05). CONCLUSION: HAb18G/CD147 antagonistic peptides (AP-1-AP-9) have inhibitory effects on many aspects or steps associated with metastasis of HCC, which provides avenue to explore medication for preventing metastasis of HCC.

[Bio-Panning of Antagonistic Peptides Against HAb18G/CD147 and Their Function of Anti-Hepatoma Invasion].

Effects of HAb18G/CD147 antagonistic peptides on invasion and metastasis of HCC

Screening and Identification of A Targeting Peptide to Hepatocarcinoma from A Phage Display Peptide Library

[Phage Display Random Peptide Library for Screening the Peptides That Specifically Bind to Hepatocellular Carcinoma Cells].

Screening and identification of hepatocellular carcinoma cell specific binding peptides using phage display peptide library

In vitro panning of a targeting peptide to hepatocarcinoma from a phage display peptide library.

Selection of the Peptides Specifically Binding to Hepatoma by Using Phage Display in Vivo

Study on the affinities of antagonistic peptides with HAb18G/CD147 on the hepa tocellular carcinoma cells

Screening and Identification of a Specific Peptide Binding to Hepatocellular Carcinoma Cells from a Phage Display Peptide Library

Screening and Characterization of Multi-Peptide Binding Specifically to Hepatocellular Carcinoma Cells by Phage Peptide Library

Biopanning and Identification of Peptides Capable to Inhibit the Interaction Between Hcd81 and HCV E2 Protein

Selection and Preliminary Identification of Hepatocarcinoma-Binding and Internalizing Peptide

Identification and Localization of Hepatocarcinoma-Specific Adhesion Peptide

Phage Display Selection of Peptides That Inhibit Metastasis Ability of Gastric Cancer Cells with High Liver-Metastatic Potential.

[Effects of High Metastatic Potential Hepatocellular Carcinoma Cell-Binding Peptide on the Invasion and Metastasis of Liver Cancer].

Biopanning of HGV epitope from a phage displayed library

HAb18G(/CD147) peptide agonist and its prepn and use

Inhibitory Effects of Antisense RNA of HAb18G/CD147 on Invasion of Hepatocellular Carcinoma Cells in Vitro.

Bio-panning of HGV E2 Epitope from a Phage-Displayed Random Peptide Library

Targeting of Hepatoma Cell and Suppression of Tumor Growth by A Novel 12mer Peptide Fused to Superantigen Tsst-1

Targeted Drug Delivery to Hepatocarcinoma in Vivo by Phage-Displayed Specific Binding Peptide.